Nocdurna (Desmopressin)

Desmopressin, the active ingredient in Nocdurna, is a vasopressin analog presented as a sublingual formulation for sublingual use. It mimics the natural antidiuretic hormone to reduce excessive urine output and to promote clotting factor stability, and it is employed to manage central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders such as mild hemophilia A and von Willebrand disease.

GNH USA supplies Nocdurna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to regulate water balance and coagulation. - Central diabetes insipidus: reduces polyuria and concentrates urine, helping maintain fluid balance. - Nocturnal enuresis: decreases nighttime urine production, reducing bedwetting episodes. - Mild hemophilia A and von Willebrand disease: raises plasma levels of factor VIII and von Willebrand factor, improving clot formation.

Desmopressin may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head. - Nausea: upset stomach or feeling of queasiness. - Nasal congestion: sensation of a blocked nose. - Mild hyponatremia: slight reduction in serum sodium, often asymptomatic.

Serious or Rare Side Effects: - Severe hyponatremia with seizures: marked sodium drop leading to neurological symptoms. - Thromboembolic events: rare formation of blood clots. - Allergic reactions: rash, itching, swelling, or other hypersensitivity signs.

When prescribing Nocdurna, clinicians should consider several safety measures. - Dose titration: adjust dose based on urine output and serum sodium levels. - Fluid restriction: limit excessive water intake to reduce hyponatremia risk. - Monitor electrolytes: regularly check serum sodium during therapy. - Cardiovascular disease: use caution in patients with heart failure or hypertension. - Pregnancy and lactation: evaluate risk–benefit as safety data are limited. - Store at room temperature: keep below 25°C in original packaging, protect from moisture.

Desmopressin can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Thiazide diuretics: may exacerbate hyponatremia. - NSAIDs (e.g., ibuprofen): can potentiate antidiuretic effect and increase water retention. - Other antidiuretic agents (e.g., carbamazepine): additive risk of low sodium.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): desmopressin may enhance clotting factor levels, affecting monitoring. - SSRIs (e.g., fluoxetine): possible increased risk of hyponatremia. - Alcohol: may potentiate central nervous system effects.